Publication date Issuer Person discharging managerial responsibilities Position Closely associated Nature of transaction Instrument name Intrument type ISIN Transaction date Volume Unit Price Currency Status Details
23/02/2024 Egetis Therapeutics AB (publ) Nicklas Westerholm Chief Executive Officer (CEO)/Managing Directory Acquisition Egetis Therapeutics AB Share SE0003815604 23/02/2024 19,600 Quantity 6.10 SEK Notification
11/07/2023 Egetis Therapeutics AB (publ) Henrik Krook Other member of the company's administrative, management or supervisory body Acquisition Egetis Therapeutics AB Share SE0003815604 07/07/2023 33,594 Quantity 3.98 SEK Notification
04/07/2023 Egetis Therapeutics AB (publ) Nicklas Westerholm Chief Executive Officer (CEO)/Managing Directory Acquisition Egetis Therapeutics AB Share SE0003815604 04/07/2023 15,350 Quantity 3.95 SEK Notification
15/06/2023 Egetis Therapeutics AB (publ) Gunilla Osswald Member of the Board of Directors Acquisition Egetis Therapeutics AB Share SE0003815604 15/06/2023 40,000 Quantity 5.14 SEK Notification
07/06/2023 Egetis Therapeutics AB (publ) Elisabeth Svanberg Member of the Board of Directors Acquisition Aktie Share SE0003815604 05/06/2023 10,280 Quantity 5.31 SEK Notification
01/06/2023 Egetis Therapeutics AB (publ) Kristina Sjöblom Nygren Other member of the company's administrative, management or supervisory body Acquisition Egetis Therapeutics AB Share SE0003815604 01/06/2023 5,000 Quantity 4.93 SEK Notification
31/05/2023 Egetis Therapeutics AB (publ) Mats Blom Member of the Board of Directors Acquisition Egtis Therapeutics Share SE0003815604 31/05/2023 200,000 Quantity 4.958 SEK Notification
21/06/2022 Egetis Therapeutics AB (publ) Henrik Krook Other senior executive Yes Disposal Egetis Therapeutics AB Share SE0003815604 20/06/2022 84,999 Quantity 3.227 SEK Notification
21/06/2022 Egetis Therapeutics AB (publ) Henrik Krook Other senior executive Yes Acquisition Egetis Therapeutics AB Share SE0003815604 20/06/2022 84,999 Quantity 3.308 SEK Notification
20/05/2022 Egetis Therapeutics AB (publ) Henrik Krook Other senior executive Yes Subscription Egetis Therapeutics AB BTA BTA SE0017770027 17/05/2022 135,999 Quantity 3.65 SEK Notification
Showing 1 to 10 of 51 result